baber/WOPTO huggingface dataset:
Patent JP-2001519862-A (JP)
IPC: D06M15/256
Filed: 1998-10-08
Abstract: A firefighting garment (10) including: an outer shell (26) of abrasion, flame and heat resistant material selected from a group consisting of an aramid material, a blend of aramid materials, PBI material, and a blend of aramid and PBI materials; a thermal liner (28), positioned within the outer shell and including a batting of needlepunch or nonwoven aramid material, or a blend of such aramid materials stiched to a first face cloth layer (34) of aramid material, a knit collar (20) and arms (14, 16) having knit wristlets (42); and a second face cloth layer (32) of aramid material, positioned within the thermal liner (28); where the material of the outer shell (26), the thermal liner (28) including the collar (20) and wristlets (42), and the second face cloth layer (32) are all treated with a durable, water repellant finish. The firefighting garment (10) is relatively thin and lightweight, thereby minimizing the bulk and reducing the hobbling effect, and reducing the material costs of the garment.
Patent JP-2001519781-A (JP)
IPC: C12N5/078
Filed: 1998-03-04
Abstract: The present invention relates to a modified live or inactivated bovine respiratory coronavirus and bovine enteric coronaviruses and their antigens used as a vaccine to protect against both bovine respiratory coronavirus and bovine enteric coronavirus diseases, and processes for making and using the same.
Patent JP-2000511475-A (JP)
Title: 構成部材を固定するための装置
IPC: B23Q3/08
Filed: 1998-03-24
Abstract: (57)【要約】
構成部材（２０）、特にニューマチック部材を固定部材（２２）によって固定するための装置（１０）が提案される。この装置（１０）は、複数の互いに平行に配置された固定板（４２，４４，４６）から成っていて、これらの固定板（４２，４４，４６）はねじ（１８）によって２つの成形ロッド（１４，１６）の間に配置されている。装置（１０）の個々の固定板（４２，４４，４６）の間では、固定板（４２，４４，４６）の長辺側の側面（６６，６８，７０，７２）に設けられた溝（７４）に溝ブロック（７６，８６）が配置されている。この溝ブロック（７６，８６）は任意の数、任意の位置に設けられてよく、簡単に組み付けることができ、場合によっては生じるギャップを隠蔽し、装置（１０）の剛性を高める。
Patent JP-2001527722-A (JP)
Title: 効率的な信号電力増幅のための方法および装置
IPC: H03F3/60
Filed: 1998-04-30
Abstract: (57)【要約】
装置１００は、合成回路１２５からの電力回復を利用して効率を改善する。電力合成装置１２５は入力信号１１３，１１４を合成して複数の出力信号１２７，１３３を生成する。電力合成装置の出力の１つが電力回復回路１３５に結合され、エネルギが回復されて、好ましくは後で用いるために蓄積される。
Patent JP-2002511890-A (JP)
Title: ケラチン繊維上に一時的な染色を生じさせるための薬剤及び方法
IPC: D06L3/00
Filed: 1999-02-26
Abstract: (57)【要約】
本発明の対象は、以下の式(I)のポリメチン染料
 又はその生理学的に温和な塩の少なくとも１種を含有した、ケラチン繊維を染色するための薬剤、並びに、ケラチン繊維を一時的に染色するための方法である。
Patent JP-2002509590-A (JP)
IPC: D03D27/06
Filed: 1998-10-23
Abstract: This invention is aimed at providing a terry-cloth or velours fabric, and a predictably economic process for its production, whereby it is possible to optimally adapt the fabric to different purposes. The proposed approach is a process for producing a terry or velours fabric consisting of a carrier web and, anchored in the carrier web, a nap in the form of open or dosed loops, of a warp of cotton loops the cut or uncut loops of which extend from one surface of the carrier web, and of a warp of microfiber loops the cut or uncut loops of which protrude from the opposite surface of the carrier web, the said warp of cotton loops and, respectively, the warp of microfiber loops being interlaced on the respective surface from which they protrude at the time the carrier web is produced.
Patent MX-158614-A (MX)
Inventor: MOBIUS CHRISTIAN
IPC: C02F1/52
Filed: 1981-07-13
Abstract: 1. Method for the treatment of factory circulation water and waste waters of the paper-making and related industries for the purpose of removing dissolved or colloidally dispersed organic substances, characterized in that an acid activated clay mineral is used, of which the alkali or alkaline earth portion in dissolved practically completely out of the mineral and of which the aluminium portion is for the most part dissolved out of the mineral.
Patent NZ-201084-A (NZ)
Title: 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such
Inventor: ATWELL G J
IPC: A61K31/435
Filed: 1982-06-25
Abstract: The novel class of 4-carboxamidoacridines of the present invention represented by the general formula (I), 
<CHEM>
 where R1 represents H, CH3 or NHR3, where R3 is H, COCH3, SO2CH3, COPh, SO2Ph or lower alkyl optionally substituted with hydroxyl and/or amino functions;
 R2 represents H or up to two of the groups CH3, OCH3, halogen, CF3, NO2, NH2, NHCOCH3, and NHCOOCH3 placed at positions 1-3 and 5-8;
 Y represents C(NH)NH2, NHC(NH)NH2, or NR4R5, where each of R4 and R5 is H or lower alkyl optionally substituted with hydroxyl and/or amino functions; and
 x is from 2 to 6,
 and the acid addition salts thereof, possess antibacterial and antitumour properties.
Patent NZ-211541-A (NZ)
Title: Artificial heart:movable common wall between ventricle chambers
Inventor: LUNDBACK S
IPC: A61M60/882
Filed: 1985-03-22
Abstract: A double pump adapted for use as an artificial heart includes two ventricle-simulating chambers that are provided with respective inlets and outlets having valves incorporated therein and that are separated by a common partitioning wall structure. The wall structure has sections that are driven away from each other to reduce the volumes of respective ventricle chambers and expel liquid from the chambers through the outlets. The wall structure can also move laterally in response to differences in pressure between the chambers and hence change the volumetric ratio between them. This ensures a balanced action between the two halves of the heart- simulating pump during a systole phase and a diastole phase. The link mechanism is actuated by a cord through a motor, although only in one direction in the pressure phase, and hence the aforementioned changed volumes are readjusted primarily through the pressure exerted by the inflowing fluid. The pump may also include a variable volume atrium-simulating chamber communicating with the inlet to each ventricle-simulating chamber and having volume that is controlled in part by an externally acting gas pressure that varies in accordance with changes in the volumes of the ventricle chambers.
Patent NZ-225180-A (NZ)
Title: Grass trimmer with grass trimming and edge trimming modes
Inventor: MEAD D E
IPC: A01D34/84
Filed: 1988-06-24
Abstract: A grass trimming device is capable of adopting at least two alternative configurations, in one of which a cutting plane is substantially horizontal for use in grass trimming, and in the other of which the cutting plane is substantially vertical for edge trimming. A parting plane (A) is defined by a housing (11,22,24) of the cutting head (10) such that rotation about an axis (B) perpendicular to this plane (A) through 180 DEG  results in the required switching. The shaft axis is preferably inclined at 10-15 DEG  with respect to the turning axis (B).
Patent NZ-229422-A (NZ)
Title: Certain (2',5')-oligoadehylate derivatives and pharmaceutical use
Inventor: SUHADOLNIK ROBERT J
IPC: A61K31/7052
Filed: 1989-10-06
Abstract: Synthetic analogs of 2',5'-oligoadenylate wherein the aglycon, ribosyl moiety and/or terminal nucleoside have been modified are effective therapeutic agents, particularly against HIV infection. The analogs are utilized in compositions for the treatment of disorders characterized by 2-5A pathway defects. <IMAGE>
Patent NZ-237312-A (NZ)
Title: Container of substantially rectangular section with circular inner member and outer envelope of circular arcs
Inventor: BOOTS GERARDUS ANTHONIUS MARIA
IPC: B65D77/06
Filed: 1991-03-05
Abstract: This invention relates to a container for bulk goods, fluids and the like, comprising an outer envelope (131), which can be closed at both ends, and an inner member (132), which is connected to the outer envelope at at least four points spaced about the circumference of the outer envelope and has a length that is 30-100% of the height of the container to be formed. According to the invention, for obtaining a substantially block-shaped container with a bottom and cross-sections parallel thereto, substantially in the form of a rectangle deviating from a square, the starting-point is a rectangle with the desired outer dimensions and at least one inscribed circle which touches both long sides but not at least one short side of the rectangle. A first line extends parallel to the long side and through the centre of the inscribed circle and a second line extends parallel to a short side and through the centre of the inscribed circle. These lines divide the rectangle into subrectangles each having an angular point coinciding with one of the angular points of the rectangle. A bisector is drawn in the rectangle from each coinciding angular point. Located in each bisector is the centre of a further circle (135) which touches the long and the short side that meet at the angular point from which the corresponding bisector has been drawn. The intersections of said further circles and said inscribed circle define the points where the outer envelope is connected to the inner member. These intersections do not lie outside the subrectangle with the bisector in which lies the centre of the corresponding further circle. The length of the outer circumference of the outer envelope is defined by the sum of the four lengths of the arc of the four further circles between the points where the further circles intersect the inscribed circle and the sum of the lengths of such portions of the outer circumference of the inner member as are not covered by the further circles. <IMAGE>
Patent NZ-239639-A (NZ)
Title: Phage resistant fermentations using a bacterial culture of isogenic strains carrying different phage defense mechanisms
Inventor: KLAENHAMMER TODD ROBERT
IPC: C12N15/52
Filed: 1991-09-02
Abstract: A phage defense rotation strategy for use in the successive fermentations of a substrate in a fermentation plant is disclosed. The strategy comprises (a) fermenting substrate with a first bacterial culture comprising a bacterial strain capable of fermenting the substrate and, preferably, carrying a first phage defense mechanism; and then (b) fermenting the substrate with a second bacterial culture comprising a second bacterial strain isogenic with the first bacterial strain, wherein the second strain carries a second phage defense mechanism different from the first phage defense mechanism. Also disclosed is a mixed bacterial culture capable of fermenting a substrate. The mixed culture comprises (a) a first bacterial strain carrying a first phage defense mechanism; and (b) a second bacterial strain isogenic with the first strain, wherein the second strain carries a phage defense mechanism different from the phage defense mechanism carried by the first strain.
Patent NZ-242787-A (NZ)
Title: Apparatus for washing cows teats: two pairs of counter-rotating brushes
Inventor: FARINA FELICE
IPC: A01J7/04
Filed: 1992-05-18
Abstract: An apparatus (1) for automatically washing teats of generic dairy animals, specifically dairy cattle, comprises a box-type body (2) formed with an opening for introducing a teat (T) thereinto, and two pairs (6 and 7) of counter-rotating brushes located at the opening in the box-type body and aligned along a direction of introduction (V) of the teat (T) into the box-type body. <IMAGE>
Patent NZ-247398-A (NZ)
Title: Pharmaceutical composition comprising methanediphosphonic acid and a cationic microporous ion exchange resin
Inventor: KHANNA SATISH CHANDRA
IPC: A61K47/48
Filed: 1993-04-14
Abstract: The invention relates to a novel advantageous oral administration form for methanediphosphonates, in particular the active substance disodium pamidronate. A preferred administration form contains:   a) disodium 3-amino-1-hydroxypropane-1,1-diphosphonate (disodium pamidronate); b) cationic ion exchange resin based on a styrene/divinylbenzene copolymer with an exchangeable aminophosphonate group and, where appropriate   c) further pharmaceutically acceptable ancillary substances.   The ingredients can be processed to tablets, coated tablets, capsules etc.
Patent NZ-259747-A (NZ)
Title: Jaw crusher: stub axle cantilever supported elbowed swinging jaw with bearing support intermediate stub axles
Inventor: BETTS EDMUND WILLIAM
IPC: B02C1/04
Filed: 1994-01-26
Abstract: PCT No. PCT/GB94/00147 Sec. 371 Date Sep. 11, 1995 Sec. 102(e) Date Sep. 11, 1995 PCT Filed Jan. 26, 1994 PCT Pub. No. WO94/17912 PCT Pub. Date Aug. 18, 1994Provided herein is a cantilevered swing jaw crushing apparatus comprising a main frame, two jaws mounted on the main frame for crushing material passing through the apparatus, means for driving the jaws in a crushing action and a bearing support, wherein the cantilevered swing jaw comprises an upper portion pivotally attached to the main frame and a lower portion for cooperating with the second jaw of the apparatus, an elbow being formed between the upper portion and the lower portion and wherein the bearing support is mounted on the main frame and bears against the elbow of the cantilevered swing jaw to support the swing jaw throughout the motion of the jaw. In a crushing apparatus according to the invention, forces applied to the cantilevered swing jaw are transferred via the bearing support to the main frame rather than to the pivot axis of the swing jaw.
Patent NZ-260062-A (NZ)
Title: Enantiomers of 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(4-methylphenyl)sulphonyl]piperazine
Inventor: COSSEMENT ERIC
IPC: C07D295/04
Filed: 1994-03-10
Abstract: The use of levorotatory or dextrorotatory enantiomers of 1-(4-chlorophenyl)phenylmethylpiperazine derivatives (V) or their salts in medicines for the treatment of allergies, is new.  The use of levorotatory or dextrorotatory enantiomers of 1-(4-chlorophenyl)phenylmethylpiperazine derivatives of formula (V) or their salts, in medicines for the treatment of allergies, is new:  R  =  H, (3-methylphenyl)methyl, (4-tert-butylphenyl)methyl, 2-(2-hydroxyethoxy)ethyl, 2-(2-(hydroxyethoxy)ethoxy)ethyl, 2-(carbamoylethoxy)ethyl, 2-(methoxycarbonylmethoxy)ethyl or 2-(carboxymethoxy)ethyl.
Patent NZ-310242-A (NZ)
Title: Process for making a lithiated lithium manganese oxide spinel by contacting a lithium magnesium oxide spinel and a lithium carboxylate compound
Inventor: BOWDEN WILLIAM L
IPC: C01G45/00
Filed: 1996-06-05
Abstract: Disclosed is a process for making a lithiated lithium manganese oxide spinel of the formula Li(1+x)Mn204 comprising contacting a lithium manganese oxide spinel of the formula LiMn2O4 with a lithium carboxylate compound, at a temperature and for a time sufficient to decompose the carboxylate compound and free the lithium to form said lithiated spinel.
Patent NZ-328738-A (NZ)
Title: Hair cosmetic preparation comprising a liposomic uv absorber
Inventor: LUTHER HELMUT
IPC: A61K8/00
Filed: 1997-09-15
Abstract: An agent for protecting human hair against damage caused by UV radiation contains a compound of formula (I) with a hydrophilic end group (Z), spacer group (W), UV chromophore (Q) with an absorption range of 285-400 nm and at least one hydrophobic side group (A), where A1, A2 = hydrophobic group ; Q = UV chromophore ; W = organic group ; Z1, Z2 = hydrophilic group ; n1, n2 = 0-4 ; p, r1 = 1-2 ; q = 0-3 ; r2 = 0-1 ; and s1 = 1-3, with the proviso that n1 and n2 are not both equal to 0. Also claimed are: (i) hair cosmetic products containing 0.25-5 wt.% (I) and at least one skin or hair compatible auxiliary agent; (ii) the use of such products containing (I) for treating the hair to protect it against UV damage; and (iii) compounds of formula (II), where R11 = H, OH, 1-15C alkyl or 1-15C alkoxy ; R12 = H or 1-15C alkoxy ; A1, A2 = 8-22C alkyl ; and Hal = halogen.
Patent NZ-332119-A (NZ)
Title: Quinazoline compounds which are irreversible inhibitors of tyrosine kinases
Inventor: BRIDGES ALEXANDER JAMES
IPC: A61K31/529
Filed: 1997-04-08
Abstract: A compound having the Formula I wherein: X is -D-E-F and Y is -SR4, -OR4, -NHR3, or hydrogen; or X is -SR4, -OR4, -NHR3, or hydrogen, and Y is -D-E-F;  D is -NR2-, -O-, -CHR2-, -N-R2NH-, -NR2-O-, CHR2-NH-, CHR2-O-, -CHR2-CH2-, -NH-CHR2, -O-CHR2-, -S-CHR2- or D is absent;  E is -C(=O)-, -SO2-, -P(=O)OR2- or -S(=O)- F is -CR1=CHR5, -C=C-R5, OR -CR1=C=CHR5; provided that when E is -S(=O) OR -SO2-, D is not -NH=CHR2, or -O-CHR2; R1 is hydrogen, halogen, or alkyl; R2, R3, and R4 are independently hydrogen, alkyl, -(CH2)n-N-piperidinyl, -(CH2)n-N-piperazinyl, -(CH2)n-N1-piperazinyl[N4-alkyl], -(CH2)n-N-pyrrolidyl, -(CH2)n-pyridinyl, -(CH2)n-N-imidazoyl, -(CH2)n-imidazoyl, -(CH2)n-N-morpholino, -(CH2)n-N-thiomorpholino, -(CH2)n-N-hexahydroazepine or substituted alkyl, wherein the substituents are selected from -OH, -NH2, or -N-AB; A and B are independently hydrogen, alkyl, -(CH2)nOH, -(CH2)n-N-piperidinyl, -(CH2)n-N-piperazinyl, -(CH2)n-N1-piperazinyl[N4-alkyl], -(CH2)n-N-pyrrolidyl, -(CH2)n-N-pyridyl, -(CH2)n-imidazoyl or -(CH2)n-N-imidazoyl; Z1, Z2, or Z3 are independently hydrogen, halogen, alkyl, cycloalkyl, alkoxy, cycloalkoxy, nitro, perfluoroalkyl, hydroxy, acyloxy, -NH2, -NHalkyl, -Nalkyl2, -NHcycloalkyl, -Ncycloalkyl2, hydroxymethyl, acyl, cyano, azido, thioalkyl, sulfinylalkyl, sulfonylalkyl, thiocycloalkyl, sulfinylcycloalkyl, sulfonylcycloalkyl, mercapto, alkoxycarbonyl, cycloalkoxycarbonyl, alkenyl, cycloalkenyl, or alkynyl; R5 is hydrogen, halogen, perfluoroalkyl, 1,1-difluoroalkyl, alkyl, -(CH2)n-N-piperidinyl, -(CH2)n-piperazinyl, -(CH2)n-piperazinyl[N4-alkyl], -(CH2)n-N-pyrrolidyl, -(CH2)n-pyridinyl, -(CH2)n-N-imidazoyl, -(CH2)n-N-morpholino, -(CH2)n-N-thiomorpholino, -CH=CH2, -CH=CH-alkyl, -(CH2)n-N-hexahydroazepine, -(CH2)nNH2,-(CH2)nNHalkyl, -(CH2)nNalkyl2, -1-oxoalkyl, carboxy, alkyloxycarbonyl, N-alkylcarbamoyl, phenyl or substituted phenyl, wherein the substituted phenyl can have from one to three substituents independently selected from Z1, Z2 and Z3 or a monocyclic heteroaryl group, and each alkyl group can be substituted with -OH, -NH2 or -NAB, where A and B are as defined above; R6 is hydrogen or alkyl; and n is 1 to 4, p is 0 or 1, and the pharmaceutically acceptable salts, esters, amides, and prodrugs thereof. A compound of formula II wherein: Q is a group selected from formulae IIa; X, Y, D, E, F, R1-R6, n & p have the same meaning as in formula I; E1, E2 & E3 have the same meaning as Z1, Z2 & Z3 respectively as in formula I. A compound of formula III, wherein: Q is selected from a group of formulae IIIa; X, Y, D, E, F, R1-R6, n & p have the same meaning as in formula I; E1, E2 & E3 have the same meaning as Z1, Z2 & Z3 respectively as in formula I. These compounds irreversibly inhibit tyrosine kinases and are useful for treating or preventing restinosis and treating cancer, psoriasis, artherosclerosis and endometriosis.
Patent NZ-334933-A (NZ)
Title: Process for disaggregating waste materials which contain at least partially reusable elements
Inventor: HOBERG HEINZ
IPC: B29B17/02
Filed: 1997-10-24
Abstract: A process is disclosed for disaggregating waste materials which contain at least partially reusable elements, mainly metals, plastics and cardboard.  The waste materials are stirred in water by mechanical forces in container 2.  Large pieces, in particular plastic pieces, are coarsely crushed and soluble elements, in particular cardboard, are dissolved.  The metallic elements are separated 4 from the suspension as heavy materials, the remaining coarse solids, in particular plastics, are mechanically separated from the suspension in separating means 6, and the suspended fine solids are separated from the suspension by dewatering.
Patent NZ-337798-A (NZ)
Title: Pharmaceutical compositions containing lamivudine
Inventor: NGUYEN NGOC-ANH THI
IPC: A61K31/70
Filed: 1998-03-20
Abstract: A pharmaceutical composition comprising lamivudine that is substantially free of ethanol and containing less that 0.005% ethylenediaminetetraacetic acid and has a pH greater than 5.5. The composition also comprises a preservative system containing parabens.
Patent NZ-507432-A (NZ)
Title: Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
Inventor: BURKHOLDER TIMOTHY P
IPC: A61K/
Filed: 1999-04-30
Abstract: Disclosed are carboxy substituted acyclic carboxamide derivatives of formula (1), and stereoisomers and pharmaceutically acceptable salts thereof, wherein: R1 is from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, C1-C6 alkyl, and C1-C6 alkoxy; R2 is hydrogen or a radical chosen from the group consisting of formulas (2) and (3); R3 is selected from the group consisting of hydrogen, C1-C4 alkyl, and -CF3; Ar1 is a radical chosen from the group consisting of formulas (4)-(7); R4 is from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, hydroxy, -CF3, C1-C6 alkyl, and C1-C6 alkoxy; R5 is from 1 to 2 substituents each independently chosen from the group consisting of hydrogen, halogen, C1-C6 alkyl, and C1-C6 alkoxy; Ar2 is a radical chosen from the group consisting of formulas (8) and (9); R6 is from 1 to 3 substituents each independently chosen from the group consisting of hydrogen, halogen, -CF3, C1-C6 alkyl, and C1-C6 alkoxy; R7 is from 1 to 2 substituents each independently chosen from the group consisting of hydrogen, halogen, C1-C6 alkyl, and C1-C6 alkoxy; X is a radical selected from the group consisting of formulas (10)-(12); Y is -0- or -CH2-; p is an integer from 1 to 4; R10 is selected from the group consisting of hydrogen and C1-C6 alkyl; Preferred compounds include (R)- or (S)-N-methyl-N-(4-(4-phenyl-4-((4-carboethoxymethylpiperazin-1-yl)carboxamido)piperidino-1-yl)-2-(3,4-dichlorophenyl)butyl)-2-methoxy-5-(1H-tetrazol-1-yl)benzamide or a mixture thereof.  Such compounds are useful as tachykinin receptor antagonists, which are useful in the treatment of tachykinin-mediated diseases and conditions disclosed herein including asthma, cough, and bronchitis.
Patent NZ-508415-A (NZ)
Title: Hydrophilic polymer blends used to prevent cow skin infections
Inventor: EHRHARD JOSEPH
IPC: A01N33/18
Filed: 1999-05-20
Abstract: A mammalian teat dip composition comprising: (i) a solution of a film forming polymer blend comprising a first polymer component that is an organic, solvent-soluble, preformed, thermoplastic polyurethane having no reactive isocyanate groups and a second polymer component which is a hydrophilic poly(N-vinyl lactam). The polymer blend being capable of withstanding exposure to water without significant loss of the hydrophilic poly(B-vinyl lactam) in an amount sufficient to form a water-resistant film upon topical application to mammalian skin, and (ii) at least one antimicrobial agent in an amount sufficient to treat and protect mammalian skin from infection.
Patent NZ-512893-A (NZ)
Title: Formulation containing phenol and/or phenol derivatives with a low freezing point
Inventor: BURI MATTHIAS
IPC: C10M129/08
Filed: 1999-12-14
Abstract: The present invention relates to an aqueous formulation containing phenol and/or phenol derivatives having a low freezing point and anti-microbial activity. Described is a liquid formulation of phenol and/or phenol derivatives, in particular of o-phenyl phenol, having a pH which may be adapted to final use. Furthermore, the formulation has a freezing point of at least -7oC. Moreover, with respect to transport and storage costs the concentration of the solution of the phenol and/or phenol derivative, preferably the o-phenyl phenol solution is as high as possible to reduce the transport and storage volume. Preferred embodiments of the formulations have freezing points of - 10oC. or even -15oC. Furthermore, using the formulation the amounts of phenol and phenol derivatives may be preferably greater than 25% by wt.